Tandem Diabetes Care Inc (TNDM) - Total Liabilities

Latest as of December 2025: $725.94 Million USD

Based on the latest financial reports, Tandem Diabetes Care Inc (TNDM) has total liabilities worth $725.94 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Tandem Diabetes Care Inc cash flow conversion to assess how effectively this company generates cash.

Tandem Diabetes Care Inc - Total Liabilities Trend (2011–2025)

This chart illustrates how Tandem Diabetes Care Inc's total liabilities have evolved over time, based on quarterly financial data. Check TNDM asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Tandem Diabetes Care Inc Competitors by Total Liabilities

The table below lists competitors of Tandem Diabetes Care Inc ranked by their total liabilities.

Company Country Total Liabilities
Guangzhou Risong Intelligent Technology Holding Co Ltd
SHG:688090
China CN¥785.33 Million
PDF Solutions Inc
NASDAQ:PDFS
USA $147.68 Million
Gs Retail
KO:007070
Korea ₩4.51 Trillion
Chengdu Fusen Noble-House Industrial Co Ltd
SHE:002818
China CN¥881.12 Million
Centuria Industrial REIT
AU:CIP
Australia AU$1.51 Billion
Thangamayil Jewellery Limited
NSE:THANGAMAYL
India Rs20.80 Billion
Ecovyst Inc
NYSE:ECVT
USA $1.13 Billion
Winmark Corporation
NASDAQ:WINA
USA $80.09 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Tandem Diabetes Care Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see TNDM market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.55 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 4.68 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.82 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tandem Diabetes Care Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tandem Diabetes Care Inc (2011–2025)

The table below shows the annual total liabilities of Tandem Diabetes Care Inc from 2011 to 2025.

Year Total Liabilities Change
2025-12-31 $725.94 Million +3.03%
2024-12-31 $704.56 Million +10.26%
2023-12-31 $639.03 Million +4.27%
2022-12-31 $612.84 Million +29.83%
2021-12-31 $472.02 Million +34.82%
2020-12-31 $350.11 Million +166.99%
2019-12-31 $131.13 Million +74.80%
2018-12-31 $75.02 Million -39.74%
2017-12-31 $124.49 Million +5.22%
2016-12-31 $118.32 Million +91.92%
2015-12-31 $61.65 Million +18.81%
2014-12-31 $51.89 Million +11.17%
2013-12-31 $46.68 Million -68.00%
2012-12-31 $145.87 Million +71.06%
2011-12-31 $85.27 Million --

About Tandem Diabetes Care Inc

NASDAQ:TNDM USA Medical Devices
Market Cap
$1.33 Billion
Market Cap Rank
#7875 Global
#2202 in USA
Share Price
$19.42
Change (1 day)
-0.54%
52-Week Range
$10.12 - $28.26
All Time High
$153.21
About

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and … Read more